nimodipine has been researched along with Anterior Horn Cell Disease in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Excerpt | Relevance | Reference |
---|---|---|
"Disease progression was assessed by repeated computerized measurements of isometric force from 20 muscle groups, and calculation of global force score." | 6.67 | Can nimodipine affect progression of motor neuron disease? A double-blind pilot study. ( Abraham, M; Achiron, A; Djaldetti, R; Melamed, E; Ziv, I, 1994) |
"Disease progression was assessed by repeated computerized measurements of isometric force from 20 muscle groups, and calculation of global force score." | 2.67 | Can nimodipine affect progression of motor neuron disease? A double-blind pilot study. ( Abraham, M; Achiron, A; Djaldetti, R; Melamed, E; Ziv, I, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ziv, I | 1 |
Achiron, A | 1 |
Djaldetti, R | 1 |
Abraham, M | 1 |
Melamed, E | 1 |
1 trial available for nimodipine and Anterior Horn Cell Disease
Article | Year |
---|---|
Can nimodipine affect progression of motor neuron disease? A double-blind pilot study.
Topics: Administration, Oral; Calcium Channel Blockers; Cross-Over Studies; Disease Progression; Double-Blin | 1994 |